Author:
Barry A L,Fass R J,Anhalt J P,Neu H C,Thornsberry C,Tilton R C,Painter B G,Washington J A
Abstract
Evaluations of 5-microgram ciprofloxacin disk diffusion susceptibility tests were performed independently by seven different investigators. The results of the separate tests were combined to increase the number of resistant strains in the challenge set of microorganisms. Based on data with 2,652 isolates, the following interpretive breakpoints are tentatively proposed for use in ongoing clinical trials of ciprofloxacin: less than or equal to 15 mm, resistant (MIC greater than 2.0 micrograms/ml); 16 to 20 mm, intermediate (1.0 less than MIC less than or equal to 2.0 micrograms/ml); and greater than or equal to 21 mm, susceptible (MIC less than or equal to 1.0 micrograms/ml). Disk tests with Streptococcus spp. and with Pseudomonas maltophilia were not reliable; other microorganisms were accurately categorized by the disk diffusion test.
Publisher
American Society for Microbiology
Reference20 articles.
1. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, and oxolinic acid after in vitro selection of resistant populations;Barry A. L.;Antimicrob. Agents Chemother.,1984
2. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid;Barry A. L.;Antimicrob. Agents Chemother.,1984
3. Antibiotic susceptibility testing by a standardized single disk method;Bauer A. W.;Am. J. Clin. Pathol.,1966
4. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid;Bauernfeind A.;Eur. J. Clin. Microbiol.,1983
5. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria;Borobio M. V.;Antimicrob. Agents Chemother.,1984
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献